Highbridge Capital Management’s Merck MRK Stock Holding History

Highbridge Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-3,773	Closed	-$218K	–	746
2018 Q2	$218K	Sell	3,773 -5,135	-58%	-$290K	﹤0.01%	796
2018 Q1	$463K	Sell	8,908 -17,502	-66%	-$945K	0.01%	728
2017 Q4	$1.42M	Buy	+26,410	New	+$1.46M	0.03%	459
2017 Q2	–	Sell	-24,733	Closed	-$1.5M	–	1473
2017 Q1	$1.5M	Buy	24,733 +12,471	+102%	+$757K	0.02%	503
2016 Q4	$689K	Sell	12,262 -104	-0.8%	-$6.09K	0.01%	659
2016 Q3	$734K	Buy	+12,366	New	+$723K	0.01%	651
2016 Q2	–	Sell	-4,297	Closed	-$217K	–	1616
2016 Q1	$217K	Sell	4,297 -138,965	-97%	-$6.81M	﹤0.01%	1301
2015 Q4	$7.22M	Buy	143,262 +46,008	+47%	+$2.32M	0.11%	222
2015 Q3	$4.58M	Buy	97,254 +74,512	+328%	+$3.96M	0.07%	321
2015 Q2	$1.24M	Sell	22,742 -45,797	-67%	-$2.57M	0.02%	664
2015 Q1	$3.76M	Buy	68,539 +14,253	+26%	+$807K	0.05%	377
2014 Q4	$2.94M	Buy	54,286 +20,016	+58%	+$1.12M	0.04%	396
2014 Q3	$1.94M	Buy	34,270 +21,904	+177%	+$1.23M	0.03%	495
2014 Q2	$682K	Buy	12,366 +3,772	+44%	+$206K	0.01%	663
2014 Q1	$466K	Buy	+8,594	New	+$445K	0.01%	721
2013 Q4	–	Sell	-89,604	Closed	-$4.07M	–	1235
2013 Q3	$4.07M	Buy	89,604 +10,270	+13%	+$469K	0.04%	372
2013 Q2	$3.52M	Buy	+79,334	New	+$3.54M	0.03%	376

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Highbridge Capital Management's MRK Position: Q4 2018 in Review

Highbridge Capital Management sold out of Merck (MRK) in Q4 2018, closing a stake of 54,066 shares — an estimated $3.66M sold.

Highbridge Capital Management first reported a position in MRK in Q2 2013 and held it in 21 quarters. The position peaked at $68.9M in Q2 2015. 2,250 funds tracked by Wall St. Rank hold MRK as of Q4 2018.

Highbridge Capital Management reported no remaining Merck position as of Q4 2018 after selling out during the quarter.
Highbridge Capital Management sold 54,066 Merck shares in Q4 2018, an estimated $3.66M.
Highbridge Capital Management first reported a position in Merck in Q2 2013 and held it in 21 quarters.
Highbridge Capital Management's Merck position peaked at $68.9M in Q2 2015.
2,250 funds tracked by Wall St. Rank held Merck as of Q4 2018.

Based on Highbridge Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.